Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004192724> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2004192724 endingPage "1239" @default.
- W2004192724 startingPage "1233" @default.
- W2004192724 abstract "Tumor cells genetically modified to express immunostimulatory molecules can produce high levels of antitumor immunity in rodent models. Although a number of clinical trials are currently in progress to assess the value of the approach in human disease, almost all require ex vivo transduction of cultured tumor cells with retroviral vectors. This process is not feasible for many human malignancies, hampering clinical evaluation of the approach. We have used an E1a, 1b/E3 deletion mutant of adenovirus containing either the lacZ or the human interleukin-2 (IL-2) gene to transduce human neuroblastoma cells. This vector transduces fresh neuroblastoma cells and neuroblastoma cell lines with an efficiency of 80–90%, compared to an efficiency of 0–14% obtained with retroviral vectors. Cells transduced with the IL-2 adenovector produce up to 12,000 pg of IL-2/106 cells/24 hr. IL-2 adenovector-transduced neuroblasts are immunostimulatory; when they are cultured with patient lymphocytes, they increase the proportion of DR+ T cells and generate major histocompatibility complex (MHC) unrestricted cytotoxic effector cells active against parental (nontransduced) tumor cells. We conclude that II-2 adenovector can be used to transduce freshly isolated human tumor cells efficiently, which will then produce immunomodulatory quantities of the cytokine. The use of adenoviral rather than retroviral vectors facilitates preparation of human tumor “vaccines” and these vectors are now being used in our clinical study of neuroblastoma patients. Many animal models have shown that modification of tumor cells with genes encoding immunostimulatory molecules effectively generates antitumor immune responses. Investigation of this approach in human disease has been hampered by difficulties in transducing many types of freshly isolated primary tumor cells. We now show that adenovectors can be highly effective transducing agents for primary tumor cells. We have shown that adenovectors transduce fresh neuroblastoma cells with high efficiency and induce them to secrete immunostimulatory molecules such as interleukin-2 (IL-2) for at least 10 days. Thus, adenovectors may have particular value where gene-modified primary human tumor cells are to be used as tumor immunogens. These vectors are being used in our current clinical trial." @default.
- W2004192724 created "2016-06-24" @default.
- W2004192724 creator A5031836709 @default.
- W2004192724 creator A5058287032 @default.
- W2004192724 creator A5059660893 @default.
- W2004192724 creator A5063655574 @default.
- W2004192724 creator A5073356326 @default.
- W2004192724 creator A5084948420 @default.
- W2004192724 date "1996-07-01" @default.
- W2004192724 modified "2023-10-10" @default.
- W2004192724 title "High-Efficiency Transduction of Freshly Isolated Human Tumor Cells Using Adenoviral Interleukin-2 Vectors" @default.
- W2004192724 cites W1525067447 @default.
- W2004192724 cites W1971425598 @default.
- W2004192724 cites W1972464496 @default.
- W2004192724 cites W1999157369 @default.
- W2004192724 cites W2002323372 @default.
- W2004192724 cites W2002517161 @default.
- W2004192724 cites W2014019711 @default.
- W2004192724 cites W2016749262 @default.
- W2004192724 cites W2029426142 @default.
- W2004192724 cites W2032524085 @default.
- W2004192724 cites W2055065821 @default.
- W2004192724 cites W2083378481 @default.
- W2004192724 cites W2090864647 @default.
- W2004192724 cites W2094522719 @default.
- W2004192724 cites W2176559485 @default.
- W2004192724 doi "https://doi.org/10.1089/hum.1996.7.10-1233" @default.
- W2004192724 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8793547" @default.
- W2004192724 hasPublicationYear "1996" @default.
- W2004192724 type Work @default.
- W2004192724 sameAs 2004192724 @default.
- W2004192724 citedByCount "31" @default.
- W2004192724 countsByYear W20041927242013 @default.
- W2004192724 crossrefType "journal-article" @default.
- W2004192724 hasAuthorship W2004192724A5031836709 @default.
- W2004192724 hasAuthorship W2004192724A5058287032 @default.
- W2004192724 hasAuthorship W2004192724A5059660893 @default.
- W2004192724 hasAuthorship W2004192724A5063655574 @default.
- W2004192724 hasAuthorship W2004192724A5073356326 @default.
- W2004192724 hasAuthorship W2004192724A5084948420 @default.
- W2004192724 hasConcept C104317684 @default.
- W2004192724 hasConcept C111599444 @default.
- W2004192724 hasConcept C15152581 @default.
- W2004192724 hasConcept C153911025 @default.
- W2004192724 hasConcept C154317977 @default.
- W2004192724 hasConcept C159047783 @default.
- W2004192724 hasConcept C202751555 @default.
- W2004192724 hasConcept C203014093 @default.
- W2004192724 hasConcept C2776715637 @default.
- W2004192724 hasConcept C2777371288 @default.
- W2004192724 hasConcept C32470452 @default.
- W2004192724 hasConcept C40767141 @default.
- W2004192724 hasConcept C502942594 @default.
- W2004192724 hasConcept C54355233 @default.
- W2004192724 hasConcept C55493867 @default.
- W2004192724 hasConcept C81885089 @default.
- W2004192724 hasConcept C86803240 @default.
- W2004192724 hasConcept C8891405 @default.
- W2004192724 hasConceptScore W2004192724C104317684 @default.
- W2004192724 hasConceptScore W2004192724C111599444 @default.
- W2004192724 hasConceptScore W2004192724C15152581 @default.
- W2004192724 hasConceptScore W2004192724C153911025 @default.
- W2004192724 hasConceptScore W2004192724C154317977 @default.
- W2004192724 hasConceptScore W2004192724C159047783 @default.
- W2004192724 hasConceptScore W2004192724C202751555 @default.
- W2004192724 hasConceptScore W2004192724C203014093 @default.
- W2004192724 hasConceptScore W2004192724C2776715637 @default.
- W2004192724 hasConceptScore W2004192724C2777371288 @default.
- W2004192724 hasConceptScore W2004192724C32470452 @default.
- W2004192724 hasConceptScore W2004192724C40767141 @default.
- W2004192724 hasConceptScore W2004192724C502942594 @default.
- W2004192724 hasConceptScore W2004192724C54355233 @default.
- W2004192724 hasConceptScore W2004192724C55493867 @default.
- W2004192724 hasConceptScore W2004192724C81885089 @default.
- W2004192724 hasConceptScore W2004192724C86803240 @default.
- W2004192724 hasConceptScore W2004192724C8891405 @default.
- W2004192724 hasIssue "10" @default.
- W2004192724 hasLocation W20041927241 @default.
- W2004192724 hasLocation W20041927242 @default.
- W2004192724 hasOpenAccess W2004192724 @default.
- W2004192724 hasPrimaryLocation W20041927241 @default.
- W2004192724 hasRelatedWork W1996617040 @default.
- W2004192724 hasRelatedWork W2011293012 @default.
- W2004192724 hasRelatedWork W2062787494 @default.
- W2004192724 hasRelatedWork W2071332814 @default.
- W2004192724 hasRelatedWork W2347300262 @default.
- W2004192724 hasRelatedWork W2383745058 @default.
- W2004192724 hasRelatedWork W2966233672 @default.
- W2004192724 hasRelatedWork W3024900260 @default.
- W2004192724 hasRelatedWork W4212764400 @default.
- W2004192724 hasRelatedWork W4386052789 @default.
- W2004192724 hasVolume "7" @default.
- W2004192724 isParatext "false" @default.
- W2004192724 isRetracted "false" @default.
- W2004192724 magId "2004192724" @default.
- W2004192724 workType "article" @default.